. 2017 Apr 3;12(4):e0174670. doi: 10.1371/journal.pone.0174670

Table 3. Inter-individual variability (Variance Ratio; VR) for un-normalized EMGs and EMGs normalized by MDM, PDM, ^*PDM, and ^**PDM during stance phase of gait cycle, n = 10.

	RF	VL	VM	BF	ST	LG	MG
Un-normalized	0.91	0.86	0.61	0.58	0.74	0.37	0.57
MVC	1.03	1.02	0.79	1.06	1.06	1.08	1.06
MDM	0.62	0.29	0.34	0.31	0.39	0.31	0.48
PDM	0.70	0.29	0.44	0.37	0.40	0.34	0.51
^*PDM	0.83	0.39	0.56	0.43	0.63	0.32	0.55
^**PDM	0.99	0.50	0.62	0.65	0.84	0.43	0.60

RF, Rectus Femoris; VL, Vastus Lateralis; VM, Vastus Medialis; BF, Biceps Femoris; ST, Semitendinosus; LG, Lateral Gastrocnemius; ML, Medial Gastrocnemius

*PDM refers to the method of normalization by using the peak values through ADLs

**PDM refers to the method of normalization by using the peak values through ADLs and MVC.

Table 3. Inter-individual variability (Variance Ratio; VR) for un-normalized EMGs and EMGs normalized by MDM, PDM, *PDM, and **PDM during stance phase of gait cycle, n = 10.

Table 3. Inter-individual variability (Variance Ratio; VR) for un-normalized EMGs and EMGs normalized by MDM, PDM, ^*PDM, and ^**PDM during stance phase of gait cycle, n = 10.